SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Sean McCarthy to be a panelist at CED's Business Development Partnering Forum at the NC Biotech Center in Research Triangle Park, NC.
News | 12. 10. 2007
